The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Thursday broker round-up UPDATE

Thu, 06th Jun 2013 07:37

Aggreko: Goldman Sachs cuts target price from 2425p to 2125p, while retaining its buy recommendation.Alliance Pharma: FinnCap shifts target price from 35p to 38.50p and stays with its hold recommendation.APR Energy: Goldman Sachs reduces target price from 990p to 945p keeping a buy recommendation.BT Group: Liberum Capital ups target price from 315p to 345p and reiterates a buy recommendation.Daily Mail & General Trust: Numis takes target price from 910p to 1007p maintaining its buy recommendation.European Islamic Investment Bank: Westhouse Securities initiates with a target price of 7p and a buy recommendation.Great Portland Group: Espirito Santo upgrades to buy with a target price of 603p.Go-Ahead Group: Morgan Stanley increases target price from 1355p to 1475p and reiterates an equal-weight rating.G4S: UBS reduces target price from 280p to 240p keeping a neutral rating.Invensys: Morgan Stanley raises target price from 390p to 440p keeping an overweight rating. Citi ups target price from 355p to 400p and maintains a neutral rating.Johnson Matthey: Bank of America increases target price from 2400p to 2950p and upgrades from neutral to buy.Journey Group: WH Ireland shifts target price from 172.50p to 175p and maintains its buy recommendation.Man Group: Bank of America reduces target price from 170p to 130p, while retaining a buy recommendation.Optos: Investec cuts target price from 157p to 124p, while upgrading from sell to reduce.Restaurant Group: Jefferies raises target price from 500p to 575p keeping a buy recommendation.RPC Group: JP Morgan shifts target price from 491p to 496p and stays with its overweight rating.RSA Insurance Group: Morgan Stanley moves target price from 124p to 136p upgrading to overweight.Synergy Health: Canaccord Genuity ups target price from 893p to 902p, but still recommends selling.Thomas Cook Group: UBS lowers target price from 147p to 145p maintaining its neutral rating.Tribal Group: Canaccord Genuity takes target price from 180p to 200p keeping a buy recommendation.Wolseley: Goldman Sachs reduces target price from 3750p to 3600p leaving its neutral rating unchanged.WPP Group: JP Morgan increases target price from 1282p to 1353p and reiterates an overweight rating.Zattikka: Canaccord Genuity cuts target price from 110p to 90p, while leaving its speculative buy recommendation unchanged.

Related Shares

More News
9 Dec 2022 10:27

Aggreko to buy Crestchic in £122m deal

(Sharecast News) - Temporary power supplier Aggreko said on Friday that it has agreed to buy specialist equipment provider Crestchic in a £122m d...

6 Aug 2021 18:20

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

2 Aug 2021 10:07

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

8 Jul 2021 21:32

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

26 May 2021 11:15

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.